Chris currently manages HGF Oppositions and Appeals Team and is the Office Head of our Birmingham Office.
Chris' practice spans the chemical and engineering fields with particular interest in electrochemistry, fuel cells, polymers, ceramics and materials on the chemistry side as well as the health care, FMCG (e-cigarettes) automotive and construction industries.
Oppositions at the European Patent Office (EPO) provides a majority of Chris' practice where he works on high-value, business-critical patents (defensively and offensively) for a number of large clients.
Chris also has an active due diligence practice, providing advice on IP aspects of commercial M & A deals and has acted as a UK patent expert in foreign litigation.
Chris works with his clients (whether they be multinationals, SMEs or universities) to provide high-quality, focused advice to ensure that maximum returns can be achieved.
"Chris Moore [is a] patent practice leader"
"Chris Moore has his fingers in many technical pies. From chemistry to plastic electronics and fuel cells, his is the number to call for impeccable oppositions and appeals representation."
"Head of oppositions and appeals Chris Moore in Birmingham is a key patent attorney practitioner"
November 20th 2020
Chris provides pro bono IP support to a number of business incubators in the West Midlands area, including the Bizz Inn in Birmingham.
Chris regularly talks at various events to provide IP training.
Chris was, until recently, the principal examiner for the UK patent attorney professional examinations (FD4 Infringement and Validity) and is now becoming a mentor for trainees.
The European Patent Office today confirmed in Decision G4/19 of the Enlarged board of Appeal that a European patent application can be refused for ‘double patenting’. Such a refusal can …Read article
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.